Investing.com - Fresenius Medical Care (NYSE:FMS) ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Fresenius Medical Care ADR announced earnings per share of $1.2 on revenue of $4.56B. Analysts polled by Investing.com anticipated EPS of $0.61 on revenue of $5.19B.
Fresenius Medical Care ADR shares are up 26.39% from the beginning of the year , is at a new 52 weeks high. They are outperforming the EUR/USD which is down 0% from the start of the year.
Fresenius Medical Care ADR follows other major Healthcare sector earnings this month
Fresenius Medical Care ADR's report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on July 23 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar